Cargando…

Management of community-acquired bacterial pneumonia in adults: Limitations of current antibiotics and future therapies

Community-acquired bacterial pneumonia (CABP) is one of the leading causes of morbidity and mortality in India and worldwide. Evidence indicates that Gram-positive, Gram-negative, and atypical bacteria are encountered with near-equal frequency. Despite guideline recommendations and antibiotic option...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nayar, Sandeep, Hasan, Ashfaq, Waghray, Pradyut, Ramananthan, Srinivasan, Ahdal, Jaishid, Jain, Rishi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852216/ https://www.ncbi.nlm.nih.gov/pubmed/31670301 http://dx.doi.org/10.4103/lungindia.lungindia_38_19

Ejemplares similares

In Vitro activity of a Novel Benzoquinolizine Antibiotic, Levonadifloxacin (WCK 771) against Blood Stream Gram-Positive Isolates from a Tertiary Care Hospital
por: Mamtora, Dhruv, et al.
Publicado: (2020)

Overview of methicillin resistant Staphylococcus aureus mediated bone and joint infections in India
por: Prabhoo, Ram, et al.
Publicado: (2019)

Current Perspectives on Treatment of Gram-Positive Infections in India: What Is the Way Forward?
por: Kulkarni, Atul P., et al.
Publicado: (2019)

Methicillin-resistant Staphylococcus aureus in Intensive Care Unit Setting of India: A Review of Clinical Burden, Patterns of Prevalence, Preventive Measures, and Future Strategies
por: Mehta, Yatin, et al.
Publicado: (2020)

Community-Acquired Pneumonia, Bacterial
por: File, Thomas M.
Publicado: (2012)

Levonadifloxacin, a Novel Broad-Spectrum Anti-MRSA Benzoquinolizine Quinolone Agent: Review of Current Evidence
por: Bhagwat, Sachin S, et al.
Publicado: (2019)

Current and Future Considerations for the Treatment of Hospital-Acquired Pneumonia
por: Montravers, Philippe, et al.
Publicado: (2016)

Evidence and consensus recommendations for the pharmacological management of pain in India
por: Dureja, Gur Prasad, et al.
Publicado: (2017)

EE388 Cost Effectiveness of Novel Antibiotic Ceftolozane/Tazobactam in Patients With Hospital-Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia in Greece
por: Yfantopoulos, N, et al.
Publicado: (2022)

Community-Acquired Bacterial Pneumonia—Changing Epidemiology, Resistance Patterns, and Newer Antibiotics: Spotlight on Delafloxacin
por: Sharma, Roopali, et al.
Publicado: (2020)

Combination antibiotic therapy for community-acquired pneumonia
por: Caballero, Jesus, et al.
Publicado: (2011)

Incidence of Antibiotic Treatment Failure in Patients with Nursing Home-Acquired Pneumonia and Community Acquired Pneumonia
por: Lopes, Mariana, et al.
Publicado: (2021)

PNEUMONIA | Community Acquired Pneumonia, Bacterial and Other Common Pathogens
por: Niederman, M.S.
Publicado: (2006)

P24 Auditing antibiotic course lengths for the management of community-acquired pneumonia and hospital-acquired pneumonia against current NICE guidance
por: Chua, Elaine, et al.
Publicado: (2023)

Correction to: Community-Acquired Bacterial Pneumonia—Changing Epidemiology, Resistance Patterns, and Newer Antibiotics: Spotlight on Delafloxacin
por: Sharma, Roopali, et al.
Publicado: (2021)

Aerosolized antibiotics in the treatment of hospital-acquired pneumonia/ventilator-associated pneumonia
por: Jung, Yun Jung, et al.
Publicado: (2022)

Community-acquired bacterial pneumonia in adults: An update
por: Eshwara, Vandana Kalwaje, et al.
Publicado: (2020)

Guideline for Antibiotic Use in Adults with Community-acquired Pneumonia
por: Lee, Mi Suk, et al.
Publicado: (2018)

Clinical response to antibiotic therapy for community-acquired pneumonia
por: Juvén, Taina, et al.
Publicado: (2004)

Community-Acquired Pneumonia and Hospital-Acquired Pneumonia in Adult Patients with Idiopathic Inflammatory Myopathy: Outcome and Antibiotic Therapy
por: Liang, Junyu, et al.
Publicado: (2020)

1991. Implementation of Rapid Turnaround PCR Bacterial/Viral Panel Testing in Community-acquired Pneumonia Decreases LOS, Antibiotic Cost, Antibiotic Charges, and Antibiotic Use
por: Shadowen, Rebecca D, et al.
Publicado: (2019)

Bacterial etiology and mortality rate in community-acquired pneumonia, healthcare-associated pneumonia and hospital-acquired pneumonia in Thai university hospital
por: Poovieng, Jaturon, et al.
Publicado: (2022)

Viral and bacterial aetiology of community‐acquired pneumonia in adults
por: Huijskens, Elisabeth G. W., et al.
Publicado: (2012)

Lefamulin vs moxifloxacin for community-acquired bacterial pneumonia
por: Tang, Hung-Jen, et al.
Publicado: (2020)

Approach to Common Bacterial Infections: Community-Acquired Pneumonia
por: Iroh Tam, Pui-Ying
Publicado: (2013)

Challenges of Empirical Antibiotic Therapy for Community-Acquired Pneumonia in Children
por: Rodrigues, Charlene M.C.
Publicado: (2017)

Analysis of antibiotic usage for viral community-acquired pneumonia in adults
por: Jiang, Rongmeng, et al.
Publicado: (2020)

Antibiotics for paediatric community-acquired pneumonia in resource-constrained settings
por: Ginsburg, Amy Sarah, et al.
Publicado: (2020)

Initial use of one or two antibiotics for critically ill patients with community-acquired pneumonia: impact on survival and bacterial resistance
por: Adrie, Christophe, et al.
Publicado: (2013)

Lefamulin, a recently approved novel antibacterial agent to fight against community-acquired bacterial pneumonia
por: Choudhury, Shouvik, et al.
Publicado: (2021)

519. Longer Length of Antibiotic Therapy for Community-Acquired Pneumonia and Risk of Clostridium difficile Infection
por: Yi, Sarah H, et al.
Publicado: (2018)

Risk factor-based analysis of community-acquired pneumonia, healthcare-associated pneumonia and hospital-acquired pneumonia: Microbiological distribution, antibiotic resistance, and clinical outcomes
por: Hyun, Hakjun, et al.
Publicado: (2022)

Potential role of tigecycline in the treatment of community-acquired bacterial pneumonia
por: Townsend, Mary L, et al.
Publicado: (2011)

Inflammatory response in mixed viral-bacterial community-acquired pneumonia
por: Bello, Salvador, et al.
Publicado: (2014)

Impact of bacterial and viral coinfection in community-acquired pneumonia in adults
por: Lim, Yong Kwan, et al.
Publicado: (2019)

810 Antibiotic Treatment Patterns and Outcomes Following Outpatient Treatment of Community-Acquired Bacterial Pneumonia: A US Cohort Study
por: Eapen, Sara, et al.
Publicado: (2014)

Use of intravenous antibiotics for the treatment of community-acquired pneumonia in the emergency department
por: Carrie, Anita G, et al.
Publicado: (2005)

Overprescription of antibiotics in patients with community-acquired pneumonia in the intensive care unit
por: Hooten, Rorak, et al.
Publicado: (2019)

Prescription of antibiotics in community-acquired pneumonia in children: are we following the recommendations?
por: da Fonseca Lima, Eduardo Jorge, et al.
Publicado: (2016)

Viewing the Community-acquired Pneumonia Guidelines through an Antibiotic Stewardship Lens
por: Fabre, Valeria, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_65tball7s37bov73dgh9431l4l